(Q36385705)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059748%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059748%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

main subject

hepatocellular carcinoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059748%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Li-Chun Lu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059748%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Ann-Lii Cheng

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059748%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Z-Z Lin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059748%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

C Hsu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059748%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Y-C Shen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059748%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

C-H Hsu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059748%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

language of work or name

English

0 references

publication date

11 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059748%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

10 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059748%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059748%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059748%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

1672-1677

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059748%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bjc.2012.466

10 March 2020

exact match

0 references

cites work

Factors impacting prognosis prediction in BCLC stage C and Child-Pugh class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3493875

Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3493875

Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3493875

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3493875

Sorafenib in advanced hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3493875

Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3493875

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3493875

Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3493875

Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3493875

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3493875

Prognosis of hepatocellular carcinoma: the BCLC staging classification

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3493875

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3493875

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3493875

Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma.

28 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.466

Hepatitis B- and C-related hepatocellular carcinomas yield different clinical features and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.466

Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.466

Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.466

Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.466

Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade--results of an explorative CGH meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.466

Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.466

Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.466

Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.466

Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinoma.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3493875

Efficacy, Safety, and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular Carcinoma

21 September 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.466

A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23059748

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23059748

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A new staging system is more discriminant than conventional staging systems for unresectable hepatocellular carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23059748

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.2012.466

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059748%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059748%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

PubMed publication ID

23059748

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059748%20AND%20SRC:MED&resulttype=core&format=json